ஜெநெரிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஜெநெரிக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஜெநெரிக் Today - Breaking & Trending Today
The company said the tablet is the bioequivalent and therapeutically equivalent to the Theophylline extended-release tablets, 300 mg and 450 mg, of Alembic Pharmaceuticals Limited.It i ....
The company said the tablet is the bioequivalent and therapeutically equivalent to the Theophylline extended-release tablets, 300 mg and 450 mg, of Alembic Pharmaceuticals Limited.It i ....
Generic Gold Corp.: Generic Gold Commences Drilling for Gold and VMS on Belvais Project, Quebec Generic Gold Corp. (CSE: GGC) (FSE: 1WD) (OCTQB: GGCPF) ( Generic or the Company ) is pleased to announce that drilling is underway on the Company s inaugural diamond drill program on its Belvais Project, located in the Abitibi Greenstone Belt of Québec, along the Normétal Fault Zone. This large, fully funded 7,500m drill program will be drilled in two phases and will target both orogenic gold and gold-rich VMS targets. The initial 3,000m for Phase 1 has commenced, with the additional 4,500m of Phase 2 planned upon receipt of Phase 1 assays. As previously announced (see release dated May 6, 2021), drill targets were generated following compilation of all available data, including recently completed VTEM and soil sampling surveys, as well as historical drilling analysis and geophysical work. As shown in ....
DRAP seeks opinion on generic medicines registration National May 12, 2021 Islamabad: Drug Regulatory Authority of Pakistan (DRAP) Tuesday decided to take initiative on the issue of registration of a generic basis for all single-ingredient drugs in consultation with relevant stakeholders. In this regard DRAP’s Division of Pharmaceutical Evaluation and Registration has sought an opinion from stakeholders on generic medicines, an official of DRAP said. He said that DRAP’s initiative on this matter is in compliance with the law for generic medicines like the Drugs Act 1976 and rules framed there under which is part of the DRAP Act 2012 under Schedule -VI. ....
April 26, 2021 For checking efficacy across demographics Optimus Pharma has applied for emergency approval for Phase 3 clinical trial of its generic version of Molnupiravir from the Drugs Controller General of India. “Phase 2a clinical trial study on enrolled 202 non-hospitalised adults is already made available. Virological analysis was characterized by marked decrease in positive viral culture in subjects who received Molnupiravir (all doses) relative to placebo - at day 5: 0% (0/47) for Molnupiravir and 24 pc (6/25) for placebo,’’ the Hyderabad-based company said in a release. Furthermore, secondary objective for faster decrease in infectious virus among people with early Covid-19 who were treated with Molnupiravir are encouraging and phase-3 clinical trials were warranted for checking the efficacy of the molecule across demographics, particularly as the SARS-CoV-2 virus, it added. ....